Save Search

1 to 16

Sort By:

Date Target Transaction Type
Value: $mlns
Acquirer Seller
2025-11-20 Care Fusion Rx
Life Science
Garden Grove, California
www.carefusionrx.com

Care Fusion Rx is a speciality infusion pharmacy focused on chronic IVIG and speciality biologic therapies. Care Fusion Rx is headquartered in Garden Grove, California.

Advisors: Polsinelli , Covington Associates
Merger

Reliant Healthcare
Company
Healthcare Services
Texarkana, Texas
www.rhcrx.com

Advisors: Bass, Berry & Sims , Brentwood Capital Advisors

-
Deal Article Deal Link  
2025-11-13 Mersana Therapeutics
Life Science
Cambridge, Massachusetts
www.mersana.com

Mersana Therapeutics is a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. Mersana Therapeutics was founded in 2001 and is based in Cambridge, Massachusetts.

Revenue (mlns) 40 USD
Advisor: Wilmer Cutler Pickering Hale and Dorr
Merger
Value

$285

7.1x Revenue

Day One
Company
Life Science
South San Francisco, California
www.dayonebio.com

Advisors: Fenwick & West , Gordon Dyal & Co. Advisory Group

-
Deal Article Deal Link  
2025-10-26 Avidity Biosciences
Life Science
San Diego, California
www.aviditybiosciences.com

Avidity Biosciences is a biotechnology company that develops oligonucleotide-based therapies using its proprietary antibody oligonucleotide conjugate platform. Avidity Biosciences was founded in 2012 and is based in San Diego, California.

Revenue (mlns) 11 USD
Advisors: Kirkland & Ellis , Goldman Sachs , Barclays Investment Bank
Merger
Value

$12,000

1118.4x Revenue

Novartis
Company
Life Science
Basel, Switzerland
www.novartis.com

-
Deal Article Deal Link  
2025-09-30 Clywedog Therapeutics
Life Science
Altrincham, United Kingdom

Clywedog Therapeutics is a clinical-stage biopharmaceutical company poised for growth in the public markets, developing advanced therapies for metabolic and autoimmune diseases. Clywedog Therapeutics is based in Altrincham, United Kingdom.

Advisor: Snell & Wilmer
Merger

Clywedog Therapeutics
Company
Life Science
Didcot, United Kingdom
www.barinthusbio.com

Advisors: Goodwin Procter , Oppenheimer & Co.

-
Deal Article Deal Link  
2025-08-25 scPharmaceuticals
Life Science
Burlington, Massachusetts
www.scpharmaceuticals.com

scPharmaceuticals is a commercial-stage pharmaceutical company focused on redefining cardiorenal care with integrated treatments designed to address the unmet needs of patients. scPharmaceuticals was founded in 2013 and is headquartered in Burlington, Massachusetts.

Revenue (mlns) 36 USD
Advisors: Latham & Watkins , Leerink Partners
Merger
Value

$360

10x Revenue

MannKind
Company
Life Science
Danbury, Connecticut
www.mannkindcorp.com

Advisors: Cooley , Jefferies

-
Deal Article Deal Link  
2025-06-23 Kineta
Life Science
Mercer Island, Washington
www.kinetabio.com

Kineta is a clinical-stage biotechnology company that develops immunotherapies to transform patients’ lives. it is focused on discovering and developing potentially differentiated immunotherapies that address the major challenges with current cancer therapy. Kineta is based in Mercer Island, Washington.

Merger

TuHURA Biosciences
Company
Life Science
Tampa, Florida
www.tuhurabio.com

-
Deal Article Deal Link  
2025-05-27 PharmaCord
Life Science
Jeffersonville, Indiana
www.pharmacord.com

PharmaCord is a pharma services company that serves as a commercialization partner for life sciences organizations to enhance the patient experience. The company's comprehensive solutions support the patient journey for specialty medications through a range of services that raise awareness, facilitate access to treatment, improve affordability, and promote therapy adherence. PharmaCord is based in Jeffersonville, Indiana.

Merger

Valeris
Company
Life Science
Morrisville, North Carolina
www.valeris.com

Permira
Investor
Private Equity Firm
London, United Kingdom
www.permira.com

Deal Article Deal Link  
2025-05-01 Kronos Bio
Life Science
San Mateo, California
www.kronosbio.com

Kronos Bio is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes by targeting dysregulated transcription. Kronos Bio was founded in 2017 and is based in San Mateo, California.

Revenue (mlns) 10 USD
Advisors: Goodwin Procter , Gibson, Dunn & Crutcher , Leerink Partners
Merger
Value

$35

3.6x Revenue

Concentra Biosciences
Company
Life Science
San Diego, California
www.concentrabiosciences.com

-
Deal Article Deal Link  
2025-04-30 Regulus Therapeutics
Life Science
San Diego, California
www.regulusrx.com

Regulus Therapeutics is a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs. Regulus Therapeutics was founded in 2007 and is based in San Diego, California.

Advisors: Latham & Watkins , Evercore Group
Merger
Value

$800

Novartis
Company
Life Science
Basel, Switzerland
www.novartis.com

-
Deal Article Deal Link  
2025-04-02 Allakos
Life Science
San Carlos, California
www.allakos.com

Allakos is a clinical-stage biotechnology company developing therapies to treat various allergic and inflammatory diseases. Allakos is primarily focused on eosinophilic gastrointestinal disorders (EGIDs), leveraging industry-leading expertise in eosinophil and mast cell biology. Allakos was founded in 2012 and is based in San Carlos, California.

Advisor: Wilson Sonsini Goodrich & Rosati
Merger

Concentra Biosciences
Company
Life Science
San Diego, California
www.concentrabiosciences.com

Advisor: Gibson, Dunn & Crutcher

-
Deal Article Deal Link  
2025-03-18 Allovir
Life Science
Waltham, Massachusetts
www.allovir.com

Allovir is a developer of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The company’s technology platforms deliver commercially scalable solutions by leveraging off-the-shelf, allogeneic, multi-virus specific T-cells targeting devastating viral pathogens for immunocompromised patients under viral attack. AlloVir’s technology and manufacturing process enables the potential for the treatment and/or prevention of up to six devastating viruses with each single allogeneic cell therapy. The company is advancing multiple mid- and late-stage clinical trials across its product portfolio. AlloVir was formed in 2013 and is based in Waltham, Massachusetts.

Advisors: Goodwin Procter , Leerink Partners
Merger

Kalaris Therapeutics
Company
Life Science
Palo Alto, California
www.kalaristx.com

Advisor: Wilmer Cutler Pickering Hale and Dorr

-
Deal Article Deal Link  
2025-02-26 BioSymetrics
Life Science
Huntington, New York
www.biosymetrics.com

BioSymetrics is a AI-powered drug discovery and data analytics company, focusing on phenotype-based insights to identify novel therapeutics. BioSymetrics was founded in 2015 and is based in Huntington, New York.

Merger

Renovaro Biosciences
Company
Life Science
Los Angeles, California
www.renovarogroup.com

-
Deal Article Deal Link  
2025-01-23 Eleszto Genetika
Life Science
Budapest, Hungary
www.elesztogenetika.com

Eleszto Genetika is providing service for microbial synthetic biology including pathway design, strain construction, screening, stirred tank fermentation process development and DSP process development in yeast. Eleszto Genetika was founded in 2007 and is based in Budapest, Hungary.

Merger

Solar Biotech
Company
Life Science
Norton, Virginia
www.solarbiotech.com

-
Deal Article Deal Link  
2024-12-30 Marinus
Life Science
Radnor, Pennsylvania
www.marinuspharma.com

Marinus is a commercial-stage pharmaceutical company dedicated to the development of innovative therapeutics for seizure disorders. The Company’s product, ZTALMY (ganaxolone) oral suspension CV, is an FDA-approved prescription medication introduced in the U.S. in 2022. Marinus is based in Radnor, Pennsylvania.

Revenue (mlns) 31 USD
Advisors: Hogan Lovells , Barclays Investment Bank
Merger
Value

$151

4.9x Revenue

Immedica Pharma
Company
Life Science
Stockholm, Sweden
www.immedica.com

Advisors: Gibson, Dunn & Crutcher , MTS Health Partners

-
Deal Article Deal Link  
2024-11-26 Poseida Therapeutics
Life Science
San Diego, California
www.poseida.com

Poseida Therapeutics is a therapeutics-focused biotechnology company using best-in-class genome engineering technologies to develop novel, life-saving treatments, including gene therapies for orphan liver diseases and immuno-oncology therapeutics for several types of cancer. Poseida Therapeutics was founded in 2014 and is based in San Diego, California.

Advisors: Cooley , Centerview Partners
Merger
Value

$1,000

Roche
Company
Life Science
Basel, Switzerland
www.roche.com

Advisors: Sidley , Citi

-
Deal Article Deal Link  
2024-11-06 Sanctum Therapeutics
Life Science
Missouri City, Texas

Sanctum Therapeutics is a biotechnology company specializing in next-generation antiviral therapies. Sanctum Therapeutics is based in Missouri City, Texas.

Merger

Adnexus Biotechnologies
Company
Life Science
Dallas, Texas
www.adnexusbiotech.com

-
Deal Link  
Avg $10,562
38.1x EBITDA
157.3x REVENUE

Try Mergr Free — Access the Full List Today

Stop Manually Tracking Deals.
Get Full Access. Cancel Anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr was built to simplify the process of tracking who’s buying, selling, and what deals are happening across the private markets.

Behind every transaction is an opportunity, and Mergr gives professionals access to thousands of M&A deals, along with the investors, buyers, and sellers behind them.

The platform is powerful but easy to use — so you can quickly surface relevant transactions and move from research to action.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 217K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.